<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01030978</url>
  </required_header>
  <id_info>
    <org_study_id>0908005608</org_study_id>
    <secondary_id>3UL1RR024139-04S2</secondary_id>
    <nct_id>NCT01030978</nct_id>
  </id_info>
  <brief_title>Prevention of Type 2 Diabetes in Children With a Family-based Healthy Lifestyle Program</brief_title>
  <official_title>Prevention of Type 2 Diabetes in Children With a Family-based Healthy Lifestyle Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the Bright Bodies (BB) Healthy Lifestyle Program
      can help reverse early abnormalities in glucose metabolism and prevent the progression to
      type 2 diabetes (T2DM) in high-risk, obese youth with newly-diagnosed impaired glucose
      tolerance (IGT).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Aim: (1) To determine whether youth randomized to the Bright Bodies (BB) Healthy
      Lifestyle Program have lower 2-hr plasma glucose levels than those randomized to standard
      lifestyle counseling (control) after 6 months.

      Secondary Aims: (2) To determine if greater conversions from IGT to normal glucose tolerance
      (NGT) and less development of T2DM occurs for those in the BB vs Control Group; (3)To
      determine if there is improvement in anthropometric/metabolic parameters in BB vs Control
      Group; and (4) To determine if there is an improvement in psychosocial and family dynamic
      outcomes of the child in BB vs Control Group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>2-hour plasma glucose, category of glucose tolerance (IGT, NGT, T2DM)</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Homeostasis model assessment of insulin resistance (HOMA-IR)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid profile</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alanine aminotransferase (ALT)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index (BMI)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body fat mass and %</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure (BP)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Piers-Harris Self-concept scale score</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Child behavior checklist score</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Family assessment device (FAD) score</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Impaired Glucose Tolerance</condition>
  <arm_group>
    <arm_group_label>Family-based Healthy Lifestyle Program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects attend program with a caregiver or parent twice per week for 6 mos. Exercise is 2x/wk, behavior mod/nutrition 1 x/wk, and parent class 1 x/wk. Smart Moves curriculum is utilized for nutrition and behavior mod.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Diet &amp; Activity Education (Control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Bright Bodies Healthy Lifestyle Program</intervention_name>
    <description>Subjects attend program with a caregiver or parent twice per week for 6 mos. Exercise is 2x/wk, behavior mod/nutrition 1 x/wk, and parent class 1 x/wk. Smart Moves curriculum is utilized for nutrition and behavior mod.</description>
    <arm_group_label>Family-based Healthy Lifestyle Program</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Subjects will be given basic instruction by clinical provider and goals will be followed up every 3 months.</description>
    <arm_group_label>Standard Diet &amp; Activity Education (Control)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of IGT (glucose 140-199 at 2 hrs during OGTT)

          -  Age 11 to 16

          -  An interest in being enrolled in a healthy lifestyle program

          -  A parent/caregiver willing to participate with child in program

        Exclusion Criteria:

          -  Psychiatric disorder or serious medical condition that would preclude participation in
             program

          -  Currently taking medication that potentially effects insulin sensitivity (eg
             Metformin) or causes weight gain (example: Risperidone) or weight loss (eg Xenical)

          -  Involvement in co-existing weight management/healthy lifestyle program

          -  Plans of moving out of the Greater New Haven area within six months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert S. Sherwin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yale Center for Clinical Investigation</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2009</study_first_submitted>
  <study_first_submitted_qc>December 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2009</study_first_posted>
  <last_update_submitted>June 16, 2014</last_update_submitted>
  <last_update_submitted_qc>June 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Impaired Glucose Tolerance</keyword>
  <keyword>PreDiabetes</keyword>
  <keyword>Diabetes Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

